Skip to main content

Prescribing guidance

Items identified as low value for prescribing in NHS Wales
29/09/2022

The aim of these documents is to minimise the prescribing of medicines that offer a limited clinical benefit to patients and where more cost effective treatments may be available.

Primary care antimicrobial guidelines
22/09/2022

These guidelines aim to provide a simple effective, economical and empirical approach to the treatment of common infections; to minimise the emergence of bacterial resistance in the community.

Tramadol educational resources - 2021 review
15/07/2022

These educational resources aim to support the prescribing of tramadol in NHS Wales within the complex context of pain management.

Management of recurrent symptomatic urinary tract infection in adult women
05/07/2022

This guideline is aimed at all community and non-specialist medical, nursing and pharmacy staff involved in the prescribing and management of recurrent urinary tract infections (UTIs). This guideline is intended for non-pregnant, non-catheterised women aged 16 years and over.

Care home medicines optimisation toolkit
22/06/2022

The aim of the Care Home Medicines Optimisation Toolkit is to bring together a suite of guidance documents, tools and useful resources for care home staff and pharmacy teams who provide advice and support to care homes.

Value-based prescribing
20/06/2022

The purpose of this document is to set out the strategic approach for the value-based prescribing programme; summarising the background to the work and providing a structure for the proposed work to progress.

Management of Clostridioides difficile infection in Wales
16/03/2022

This guidance provides an evidence-based, accessible, antimicrobial prescribing strategy for managing Clostridioides difficile infection (CDI) in adults.

All Wales advice on oral anticoagulation for non-valvular atrial fibrillation
01/03/2022

This guidance focuses on treatment of patients with non-valvular atrial fibrillation (NVAF) and incorporates a risk/benefit assessment tool, and a one-page summary for Welsh healthcare practitioners choosing a direct oral anticoagulant in this patient population.

All Wales COPD management and prescribing guideline
06/12/2021

This guideline aims to reduce variation in inhaler prescribing in the management of chronic obstructive pulmonary disease (COPD) and encourage consideration of the decarbonisation agenda of NHS Wales.

All Wales adult asthma management and prescribing guideline
06/12/2021

This guideline aims to reduce variation in inhaler prescribing in the management of adult asthma and encourage consideration of the decarbonisation agenda of NHS Wales.

Prescribing dilemmas: A guide for prescribers
24/11/2021

This document provides guidance for healthcare professionals regarding prescribing duration, foodstuffs, complementary medicines and alternative therapies, common ailments, fertility treatment, erectile dysfunction, prescribing for self and family, visitors from overseas, travel and occupational health vaccines, prescribing situations not covered by the NHS including private care and private prescriptions, unlicensed medicines and prescribing outside national guidance.

All Wales advice on sodium-glucose cotransporter-2 (SGLT-2) inhibitors in type 2 diabetes and cardiovascular disease
30/09/2021

This guidance has been developed to help support healthcare professionals in the prescribing of SGLT-2 inhibitors in patients with type 2 diabetes mellitus and cardiovascular disease.

Material to support appropriate prescribing of hypnotics and anxiolytics across Wales
21/07/2021

This educational pack aims to support the appropriate prescribing of hypnotics and anxiolytics across Wales by providing key health professionals with a practical approach for the initiation and review of hypnotic and anxiolytic prescribing.

Welsh National Standards for Medication Review
02/06/2021

The Welsh National Standards for Medication Review have been developed to provide a structured approach to medication review and are benchmarks for quality, with the aim of optimising patient safety and prescribing practice.

Initial clinical management of adult smokers in secondary care
02/06/2021

This document aims to inform and guide healthcare staff in NHS Wales about how to start nicotine replacement therapy (NRT) to manage nicotine withdrawal in adults who smoke and are admitted to hospital (secondary care).

Shared care prescribing and monitoring guidance
24/02/2021

This document updates the principles of best practice for shared care prescribing agreements.

Best practice reminder: Avoid nitrofurantoin in the treatment of pyelonephritis
24/02/2021

This short ‘Best Practice Reminder’ document has been developed to inform primary care prescribers about avoiding the prescribing of nitrofurantoin in patients with suspected pyelonephritis, the rationale behind this and what can be prescribed in its place.

Safeguarding users of opioid patches by standardising patient and caregiver counselling
22/12/2020

The aim of the counselling checklist is to assist healthcare professionals, working in community pharmacies, primary care and secondary care, in the essential counselling of patients on the safe and effective use of opioid patches.

Persistent pain resources
22/12/2020

This resource pack provides healthcare professionals with signposting and access to appropriate, relevant and up-to-date information on the non-pharmacological and pharmacological management of persistent (chronic) non-malignant pain in non-specialist settings.

All Wales Guidance for Health Boards/Trusts and Social Care Providers in Respect of Medicines and Care Support Workers
19/06/2020

This guidance is intended to provide managers, responsible individuals, registered nurses and care support workers in Welsh organisations with information on how and when a registered nurse may delegate the task of medicines support to a care support worker, and the necessary education and training standards, and policies and procedures that are required to facilitate this.

Follow AWTTC: